Publisher
Springer Berlin Heidelberg
Reference10 articles.
1. Beukelman T, Ringold S, Davis TE (2012) Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis. A cross-sectional analysis of the CARRA Registry. J Rheumatol 39:1867–1874
2. Carvounis PR, Herman DC et al (2006) Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Arch Clin Exp Ophthalmol 244:281–290
3. Heiligenhaus A, Minden K, Tappeiner C et al (2019) Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Semin Arthritis Rheum 49:43–55
4. Heiligenhaus A, Tappeiner C, Neudorf U (2022) Uveitis bei Kindern und Jugendlichen mit juveniler idiopathischer Arthritis. In: Wagner N, Dannecker G, Kallinich T (Eds) Pädiatrische Rheumatologie. Springer, Berlin/Heidelberg, pp 413–427
5. Kotaniemi K, Kaipiainen-Seppanen O, Savolainen A, Karma A (1999) A population-based study on uveitis in juvenile rheumatoid arthritis. Clin Exp Rheumatol 17:119–122